Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
GRAL
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
☁️ News word cloud
Top words across the last 50 articles for this ticker.
grail
cancer
market
court
tariffs
illumina
galleri
detection
potential
investigation
2026
against
stocks
global
recommends
revenue
2030
testing
quest
diagnostics
52w high -49.8%
GRAL
GRAIL, Inc. Common Stock
Stonvex